パン癌プロテオゲノミクスは,腫瘍原発を機能的状態と結びつける
Yize Li1, Eduard Porta-Pardo2, Collin Tokheim3
1Department of Medicine, Washington University in St. Louis, St. Louis, MO 63110, USA; McDonnell Genome Institute, Washington University in St. Louis, St. Louis, MO 63108, USA.
Cell
|August 15, 2023
まとめ
この研究は,マルチオミクスのデータを用いて,がんの誘導因子の遺伝子変化が細胞プロセスにどのように影響するかを明らかにしています. 総合的なプロテオゲノミクスは癌の発達と 潜在的な免疫療法の標的に関する新しい洞察を提供します
科学分野:
- 腫瘍学
- ゲノミクス
- プロテオミクス
- システム生物学
背景:
- 癌の誘発要因は腫瘍発生を起こす 重要な遺伝的異常ですが その分子メカニズムは 完全に理解されていません
- 個々の癌の種類を研究することで,腫瘍発生要因の影響を全面的に理解することが限られている.
研究 の 目的:
- マルチオミックスのアプローチを用いて癌の誘発因子の分子機構を調査する.
- 癌の誘発因子のシス・およびトランス効果を,様々な癌のRNA,タンパク質,およびフォスフォタンパク質レベルで特定する.
- 癌の発達を理解し,治療の脆弱性を特定するためのプロテオゲノミクスの可能性を調査する.
主な方法:
- RNA,タンパク質,およびフォスフォプロテインデータを統合したマルチオミクス全がん分析.
- 遺伝的変異のシスとトランス効果の定量化
- タンパク質の相互作用ネットワークとキナーゼ活性プロフィールの分析
- T細胞の浸透と予測された新抗原負荷の相関関係
- 多遺伝子タンパク質の豊富さに基づく癌の特徴パターンの評価.
主要な成果:
- ポイント変異や複製数の変異を含む癌の誘導因子の遺伝的変異は,タンパク質の相互作用ネットワークの再配線と関連しています.
- ほとんどのがん遺伝子は 配列ベースのキナーゼ活性プロファイルによって特徴づけられる 類似した分子状態に収束します
- 予測された新抗原負荷とT細胞浸透の間の相関は,潜在的な免疫療法標的を示唆する.
- 癌の特徴のパターンは,多遺伝子タンパク質の豊富さによって,均一から異質に変化します.
結論:
- 総合的なプロテオゲノミクスは,腫瘍発生因子の機能状態に関する貴重な洞察を提供します.
- このアプローチは個々の癌の種類を研究する限界を超えて,癌の発達についてより広範な理解を提供します.
- この発見は,免疫療法に対する潜在的な脆弱性を強調し,がんの誘発因子のメカニズム的理解を進める.
関連する概念動画
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Loss of Tumor Suppressor Gene Functions
4.9K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K


